Immunotherapies with anti-endoglin monoclonal antibody, DNA and protein vaccines against endoglin have been shown to inhibit tumor growth and metastasis by suppressing endoglin-related angiogenesis in vivo[26]–[28]. The gene discussed is ENG; the disease is neoplasm.